| Health Care Technology Industry | Healthcare Sector | Mr. Per-Anders Hedin CEO | XSTO Exchange | - ISIN |
| SE Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
SensoDetect Aktiebolag (publ) represents a significant advancement in the field of medical technology, particularly within the artificial intelligence sector focused on mental health. Established in 2005 and headquartered in Malmö, Sweden, this company pioneers in the development of groundbreaking solutions aimed at improving the lives of individuals suffering from mental illnesses. By leveraging artificial intelligence, SensoDetect Aktiebolag (publ) has positioned itself as a crucial entity in the psychiatric care arena, providing innovative diagnostic aids and treatment monitoring tools to healthcare professionals.
This diagnostic aid is a cornerstone of SensoDetect Aktiebolag (publ)'s product offerings. Specifically designed for healthcare professionals within psychiatric care, it serves as an invaluable tool for the diagnosis of ADHD and autism. Beyond its diagnostic capabilities, SensoDetect BERA also assists in the monitoring of treatment efficacy for various psychiatric conditions, offering a comprehensive approach to mental health care.